Re: Hersh et al.: US multicenter clinical trial of corneal collagen crosslinking for treatment of corneal ectasia after refractive surgery (Ophthalmology. 2017;124:1475-1484)

被引：6
|
作者：
De Bernardo, Maddalena [1 ]
Rosa, Nicola [1 ]
机构：
[1] Univ Salerno, Scuola Med Salernitana, Dept Med Surg & Dent, Salerno, Italy
来源：
OPHTHALMOLOGY | 2018年 / 125卷 / 06期
关键词：
KERATOCONUS;
D O I：
10.1016/j.ophtha.2018.01.037
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：E39 / E39
页数：1
相关论文
共 9 条
  • [1] US Multicenter Clinical Trial of Corneal Collagen Crosslinking for Treatment of Corneal Ectasia after Refractive Surgery
    Hersh, Peter S.
    Stulting, R. Doyle
    Muller, David
    Durrie, Daniel S.
    Rajpal, Rajesh K.
    [J]. OPHTHALMOLOGY, 2017, 124 (10) : 1475 - 1484
  • [2] U.S. Multicenter Clinical Trial of Corneal Collagen Crosslinking for Treatment of Corneal Ectasia After Refractive Surgery (vol 124, pg 1475, 2017)
    Hersh, Peter S.
    Stulting, Doyle
    Muller, David
    Durrie, Daniel S.
    Rajpal, Rajesh K.
    [J]. OPHTHALMOLOGY, 2018, 125 (09) : 1473 - 1473
  • [3] United States Multicenter Clinical Trial of Corneal Collagen Crosslinking for Keratoconus Treatment (vol 124, pg 1259, 2017)
    Hersh, Peter S.
    Stulting, R. Doyle
    Muller, David
    Durrie, Daniel S.
    Rajpal, Rajesh K.
    [J]. OPHTHALMOLOGY, 2017, 124 (12) : 1878 - 1879
  • [4] Re: Zweifel et al.: Clinical and histopathologic findings in disseminated Mycobacterium chimera infection after cardiothoracic surgery (Ophthalmology. 2017;124:178-188)
    Watzke, Robert
    [J]. OPHTHALMOLOGY, 2018, 125 (05) : E33 - E33
  • [5] Re: Wang et al.: Comparison of newer intraocular lens power calculation methods for eyes after corneal refractive surgery (Ophthalmology 2015;122:2443-9)
    Holladay, Jack T.
    Galvis, Virgilio
    Tello, Alejandro
    [J]. OPHTHALMOLOGY, 2016, 123 (09) : E55 - E56
  • [6] Re: Weakley et al.: Myopic shift 5 years after intraocular lens implantation in the infant aphakia treatment study (Ophthalmology. 2017;124:822-827) REPLY
    Weakley, David R., Jr.
    Lynn, Michael J.
    Dubois, Lindreth
    Cotsonis, George
    Wilson, M. Edward
    Buckley, Edward G.
    Plager, David A.
    Lambert, Scott R.
    [J]. OPHTHALMOLOGY, 2018, 125 (10) : E69 - E70
  • [7] Re: Singh et al.: Nepafenac 0.3% after cataract surgery in patients with diabetic retinopathy: result of 2 randomized phase 3 studies (Ophthalmology. 2017;124:776-785)
    Grzybowski, Andrzej
    Kanclerz, Piotr
    [J]. OPHTHALMOLOGY, 2018, 125 (01) : E8 - E9
  • [8] Re: Wang et al.: Comparison of newer intraocular lens power calculation methods for eyes after corneal refractive surgery (Ophthalmology 2015;122:2443-9) REPLY
    Wang, Li
    Koch, Douglas D.
    [J]. OPHTHALMOLOGY, 2016, 123 (09) : E56 - E57
  • [9] Re: Singh et al.: Nepafenac 0.3% after cataract surgery in patients with diabetic retinopathy: results of 2 randomized phase 3 studies (Ophthalmology. 2017;124:776-785) REPLY
    Singh, Rishi P.
    Lehmann, Robert
    Martel, Joseph
    Jong, Kevin
    Pollack, Ayala
    Tsorbatzoglou, Alexis
    Staurenghi, Giovanni
    Cervantes-Coste Cervantes, Guadalupe
    Alpern, Louis
    Modi, Satish
    Svoboda, Liza
    Adewale, Adeniyi
    Jaffe, Glenn J.
    [J]. OPHTHALMOLOGY, 2018, 125 (01) : E4 - E6
1